Tenet Healthcare Projects FY Revenue of $21.5B-$22.3B
Summary
Tenet Healthcare has issued its full-year revenue guidance, projecting a range of $21.5 billion to $22.3 billion. This forward-looking financial outlook is new information, not previously detailed in the recent proxy filings or the 2025 10-K, which provided a baseline for the prior fiscal year. This guidance is a critical data point for analysts and investors, directly influencing valuation models and market expectations for the company's future performance. Traders will be assessing this range against current consensus estimates to determine potential stock price movements. Investors should monitor upcoming earnings calls for further details and any adjustments to this guidance.
At the time of this announcement, THC was trading at $180.09 on NYSE in the Life Sciences sector, with a market capitalization of approximately $15.8B. The 52-week trading range was $126.75 to $247.21. This news item was assessed with neutral market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.